Safety and Efficacy of Vilazodone in Major Depressive Disorder

Completed · Phase 4 · Has a placebo group

Conditions studied: Major Depressive Disorder

In brief

Safety and Efficacy of Vilazodone in Major Depressive Disorder

Key facts

Study ID

NCT01573598

Run by

Forest Laboratories

People needed

1219

Starts

2012-04-01

Expected to finish

2015-01-01

Last updated by the study team

2015-05-18

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men and women, 18-70 years of age
• Currently meet the DSM-IV-TR criteria for Major Depressive Disorder
• The patient's current major depressive episode must be at least 8 weeks and no longer than 18 months in duration

You may not qualify if…

• Women who are pregnant, women who will be breastfeeding during the study, and women of childbearing potential who are not practicing a reliable method of birth control
• Patients with a history of meeting DSM-IV-TR criteria for:
• any manic, hypomanic or mixed episode, including bipolar disorder and substance-induced manic, hypomanic, or mixed episode;
• any depressive episode with psychotic or catatonic features;
• panic disorder with or without agoraphobia;
• obsessive-compulsive disorder;
• Schizophrenia, schizoaffective, or other psychotic disorder;
• bulimia or anorexia nervosa;
• presence of borderline personality disorder or antisocial personality disorder; h. mental retardation, dementia, amnesia, or other cognitive disorders
• Patients who are considered a suicide risk

Where it is running

• Forest Investigative Site 012 — Chino, California, United States
• Forest Investigative Site 022 — Costa Mesa, California, United States
• Forest Investigative Site 017 — Los Angeles, California, United States
• Forest Investigative Site 005 — Newport Beach, California, United States
• Forest Investigative Site 027 — Riverside, California, United States
• Forest Investigative Site 026 — San Diego, California, United States
• Forest Investigative Site 016 — Cromwell, Connecticut, United States
• Forest Investigative Site 029 — Hartford, Connecticut, United States
• Forest Investigative Site 020 — Doral, Florida, United States
• Forest Investigative Site 007 — Fort Lauderdale, Florida, United States
• Forest Investigative Site 006 — Fort Myers, Florida, United States
• Forest Investigative Site 004 — Hallandale, Florida, United States
• Forest Investigative Site 039 — Jacksonville, Florida, United States
• Forest Investigative Site 008 — Jacksonville Beach, Florida, United States
• Forest Investigative Site 015 — Leesburg, Florida, United States
• Forest Investigative Site 035 — Orlando, Florida, United States
• Forest Investigative Site 001 — West Palm Beach, Florida, United States
• Forest Investigative Site 034 — Winter Park, Florida, United States
• Forest Investigative Site 019 — Hoffman Estates, Illinois, United States
• Forest Investigative Site 021 — Indianapolis, Indiana, United States
• Forest Investigative Site 003 — Boston, Massachusetts, United States
• Forest Investigative Site 013 — Weymouth, Massachusetts, United States
• Forest Investigative Site 028 — Rochester Hills, Michigan, United States
• Forest Investigative Site 038 — Brooklyn, New York, United States
• Forest Investigative Site 030 — Beverly Hills, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.